Skin Cancers Completed Phase 2 Trials for Temozolomide (DB00853)

Also known as: Cancer of Skin / Skin Cancer / [X]Malignant neoplasm of skin, unspecified / Skin malignant neoplasm NOS / Malignant skin neoplasm NOS / Skin neoplasms malignant and unspecified / Skin neoplasm malignant NOS / Skin neoplasm malignant

IndicationStatusPhase
DBCOND0046599 (Skin Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00804908A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic MelanomaTreatment
NCT00588341Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical ResectionTreatment
NCT00885534Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic MelanomaTreatment